Trial intelligence / Profile preview

Vascular Augmentation of Late-life Unremitted Depression

NCT01557153Phase 3Unknown

Sponsor
Gateshead Health NHS Foundation Trust
Start
Apr 2012
Primary completion
Apr 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of amlodipine in vascular depression (VD), sponsored by Gateshead Health NHS Foundation Trust. Status: unknown.

02

Drugs

amlodipine
03

Conditions

vascular depression (VD)

Beyond the preview

Go deeper on NCT01557153.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01557153.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call